NLRP3 and glaucoma: Additionally, key mediators of the Toll-like receptor pathway, inflammasome pathway, and complement cascade that have been identified in human and experimental glaucoma were also examined, specifically TLR4 [43, 44], NLRP3 [44, 45, 48], and complement components C3 and C1Q [53, 62, 63].